SCHEMBL7079261

SCHEMBL7079261

Cc1ccccc1Nc1ccc(C(=S)c2csc3ccccc23)c(Cl)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK14 Q16539 11/20 0.53
MAPK13 O15264 10/20 0.53
MAPK12 P53778 10/20 0.53
MAPK11 Q15759 10/20 0.53
PIK3CA P42336 4/20 0.41
MAOB P27338 1/20 0.39
MAPT P10636 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
PTK6 Q13882 1/20 0.36
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
GAA P10253 1/20 0.36
CYP2C19 P33261 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7568658 0.89 MAPK14 (0.43) MAPK14MAPK13MAPK12MAPK11PIK3CA
SCHEMBL7568661 0.88 MAPK14 (0.42) MAPK14MAPK13MAPK12MAPK11PIK3CA
SCHEMBL7079458 0.87 MAPK14 (0.51) MAPK14MAPK13MAPK12MAPK11PIK3CA
SCHEMBL7080292 0.87 MAPK14 (0.69) MAPK14MAPK13MAPK12MAPK11PIK3CA
SCHEMBL5174459 0.82 MAPK14 (0.71) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL7077202 0.81 MAPK14 (0.57) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL7079301 0.81 MAPK14 (0.52) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL7079304 0.79 MAPK14 (0.54) MAPK14MAPK13MAPK12MAPK11MAPT
SCHEMBL7568656 0.78 MAPK14 (0.41) MAPK14MAPK13MAPK12MAPK11PIK3CA
SCHEMBL7076169 0.78 MAPK14 (0.56) MAPK14MAPK13MAPK12MAPK11MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US claimed
US-20030073832-A1 Novel aminophenyl ketone derivatives LEO PHARMACEUTICAL PRODUCTS LTD. A/S (DK) 2003-04-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030073832-A1 Novel aminophenyl ketone derivatives MAPKAPK2, MAP3K2, MAP3K1 MAPK14 28/4885MAPK13 33/4885MAPK12 36/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.